Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP541384.RADT2zqmSeKPptcowz-KVe0MLaAx-Eugp5CcynGGl8GnY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP541384.RADT2zqmSeKPptcowz-KVe0MLaAx-Eugp5CcynGGl8GnY130_assertion type Assertion NP541384.RADT2zqmSeKPptcowz-KVe0MLaAx-Eugp5CcynGGl8GnY130_head.
- NP541384.RADT2zqmSeKPptcowz-KVe0MLaAx-Eugp5CcynGGl8GnY130_assertion description "[Compounds that inhibit kinase activity are effective growth inhibitors for poorly differentiated thyroid cancer cell lines with either RET or RAF mutations, and hold promise for treatment of most forms of papillary thyroid carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP541384.RADT2zqmSeKPptcowz-KVe0MLaAx-Eugp5CcynGGl8GnY130_provenance.
- NP541384.RADT2zqmSeKPptcowz-KVe0MLaAx-Eugp5CcynGGl8GnY130_assertion evidence source_evidence_literature NP541384.RADT2zqmSeKPptcowz-KVe0MLaAx-Eugp5CcynGGl8GnY130_provenance.
- NP541384.RADT2zqmSeKPptcowz-KVe0MLaAx-Eugp5CcynGGl8GnY130_assertion SIO_000772 16551863 NP541384.RADT2zqmSeKPptcowz-KVe0MLaAx-Eugp5CcynGGl8GnY130_provenance.
- NP541384.RADT2zqmSeKPptcowz-KVe0MLaAx-Eugp5CcynGGl8GnY130_assertion wasDerivedFrom befree-2016 NP541384.RADT2zqmSeKPptcowz-KVe0MLaAx-Eugp5CcynGGl8GnY130_provenance.
- NP541384.RADT2zqmSeKPptcowz-KVe0MLaAx-Eugp5CcynGGl8GnY130_assertion wasGeneratedBy ECO_0000203 NP541384.RADT2zqmSeKPptcowz-KVe0MLaAx-Eugp5CcynGGl8GnY130_provenance.